Shareholders' Equity - Share capital (Details) - EUR (€) |
1 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2022 |
Sep. 30, 2021 |
Jun. 30, 2025 |
Dec. 31, 2024 |
|
| Shareholders Equity | ||||
| Authorized share capital | € 13,600,000 | |||
| Par value per share | € 0.04 | |||
| Eli Lilly and Company | ||||
| Shareholders Equity | ||||
| Issue of ordinary shares (in shares) | 9,381,586 | 3,989,976 | ||
| Ordinary | ||||
| Shareholders Equity | ||||
| Number of shares issued | 107,710,916 | |||
| Number of shares authorised | 170,000,000 | |||
| Number of shares issued and fully paid | 105,344,052 | |||
| Treasury shares | 2,366,864 | 2,498,389 | ||
| Preferred | ||||
| Shareholders Equity | ||||
| Number of shares authorised | 170,000,000 | |||